Raltegravir Concentrations in the Genital Tract of HIV-1-Infected Women Treated with a Raltegravir-Containing Regimen (DIVA 01 Study)

We studied the penetration of raltegravir and HIV shedding in the genital tract among 14 HIV-1-infected women receiving a raltegravir-containing regimen who had <40 copies/ml blood plasma (BP) HIV RNA. None of the cervicovaginal fluid (CVF) samples showed detectable HIV RNA. Median raltegravir co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Clavel, Cyril, Peytavin, Gilles, Tubiana, Roland, Soulié, Cathia, Crenn-Hebert, Catherine, Heard, Isabelle, Bissuel, François, Ichou, Houria, Ferreira, Claudia, Katlama, Christine, Marcelin, Anne-Geneviève, Mandelbrot, Laurent
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101453/
https://ncbi.nlm.nih.gov/pubmed/21444705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01460-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados